Skip to main content
Fig. 4 | BMC Musculoskeletal Disorders

Fig. 4

From: Transforming growth factor-β stimulates nerve growth factor production in osteoarthritic synovium

Fig. 4

Effect of TGF-β and a TAK1 inhibitor on the phosphorylation of p38 MAPK, NGF mRNA expression, and NGF protein production. Western blotting for phosphorylated p38 MAPK (p-p38) (a, b). Synovial cells were exposed to α-MEM (control), 10 ng/mL human recombinant (rh) TGF-β (TGF-β), or 10 ng/mL rhTGF-β + 1 μM (5Z)-7-oxozeaenol (TGF-β + 5Z) for 30 min before protein extraction and western blotting. Western blot for p38 and phosphorylated p38 MAPK (p-p38) (a). Bands were analyzed by densitometry using the sNIH ImageJ software and were normalized to p38 expression. Relative p-p38/p-38 expression was determined based on the expression in control samples (b). RT-PCR (c) and ELISA (d) for NGF. Synovial cells were exposed to α-MEM (control), 10 ng/mL rhTGF-β (TGF-β), or 10 ng/mL rhTGF-β + 1 μM (5Z)-7-oxozeaenol (TGF-β + 5Z) for 6 and 24 h before RT-PCR (c) or ELISA (d). Relative expression was determined based on the expression in control samples. Data indicate mean ± SE (n = 8). *p < 0.05 compared to control. Data indicate mean ± SE (n = 8). *p < 0.05 compared to control

Back to article page